Effects of Prednisolone and Loteprednol Eyedrops on the Proliferation of Human Tenon's Capsule Fibroblasts.
10.3341/jkos.2013.54.9.1423
- Author:
Sun Hee KANG
1
;
Jae Woo KIM
Author Information
1. Department of Ophthalmology, Catholic University of Daegu School of Medicine, Daegu, Korea. jwkim@cu.ac.kr
- Publication Type:Original Article
- Keywords:
Fibroblasts;
Loteprednol etabonate;
Prednisolone acetate;
Proliferation;
TGF-beta
- MeSH:
Androstadienes;
Cicatrix;
Fibroblasts;
Filtering Surgery;
Glaucoma;
Humans;
Intraocular Pressure;
Ophthalmic Solutions;
Prednisolone;
RNA, Messenger;
Tenon Capsule;
Transforming Growth Factor beta;
Loteprednol Etabonate
- From:Journal of the Korean Ophthalmological Society
2013;54(9):1423-1428
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To compare the effect of loteprednol etabonate (LE) with prednisolone acetate (PDA) drops on the proliferation of human Tenon's capsule fibroblasts (HTFBs). METHODS: Primarily cultured HTFBs were treated with serially diluted PDA and LE for 3 days. Cellular survival was determined by a rapid colorimetric assay using MTT. RT-PCR was performed to determine the relative expression of TGF-beta mRNA in response to LE and PDA. RESULTS: PDA inhibited proliferation of HTCF in a dose-dependent manner and LE inhibited significantly the proliferation of HTCF at the higher concentration of 50 microg/ml (p < 0.05). Compared to LE, PDA inhibited proliferation of HTCF significantly at each diluted concentration (p < 0.05). Expressions of TGF-beta were decreased as the concentration of both PDA and LE increased. PDA decreased expression of TGF-beta more significantly compared to LE at each concentration (p < 0.05). CONCLUSIONS: Although LE has offered promising anti-inflammatory efficacy with decreased impact on intraocular pressure, LE may be less effective than PDA in inhibiting fibroblast proliferation and may be not comparable to PDA in preventing excessive scarring after glaucoma filtering surgery.
